News
1d
MyChesCo on MSNSEED Therapeutics Names Dr. Bill Desmarais as CFO and CBOSEED Therapeutics Inc. has announced the appointment of Dr. Bill Desmarais, Ph.D., MBA, as Chief Financial Officer and Chief ...
SEED Therapeutics Inc. ("SEED"), a biotechnology company pioneering targeted protein degradation (TPD) through the discovery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results